Literature DB >> 16483403

Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.

Kate M English1, John L Gibbs.   

Abstract

Dilated cardiomyopathy, hypertrophic cardiomyopathy, and cardiac rhythm disturbances are important features of certain neuromuscular disorders in children, adolescents, and young adults. This article summarizes the cardiac features seen in patients with Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy, Friedreich's ataxia, and Emery-Dreifuss muscular dystrophy. The optimal management of these cardiac features remains contentious, but increasingly these patients are referred for routine cardiological assessment in the absence of symptoms. This article examines the value of routine screening and drug interventions for cardiac complications in asymptomatic and symptomatic individuals with neuromuscular disorders. We recommend a pragmatic approach, actively looking for cardiac conditions which will benefit from early intervention, but avoiding routine screening for asymptomatic conditions in which there is no evidence of benefit from early intervention.

Entities:  

Mesh:

Year:  2006        PMID: 16483403     DOI: 10.1017/S0012162206000491

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  8 in total

1.  Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.

Authors:  Jill A Rafael-Fortney; Neeraj S Chimanji; Kevin E Schill; Christopher D Martin; Jason D Murray; Ranjit Ganguly; Jenna E Stangland; Tam Tran; Ying Xu; Benjamin D Canan; Tessily A Mays; Dawn A Delfín; Paul M L Janssen; Subha V Raman
Journal:  Circulation       Date:  2011-07-18       Impact factor: 29.690

2.  Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy.

Authors:  Sujatha Buddhe; Mark Lewin; Aaron Olson; Mark Ferguson; Brian D Soriano
Journal:  Pediatr Radiol       Date:  2016-05-12

3.  Fli1 Promotes Vascular Morphogenesis by Regulating Endothelial Potential of Multipotent Myogenic Progenitors.

Authors:  Anwarul Ferdous; Sarvjeet Singh; Yuxuan Luo; Md J Abedin; Nan Jiang; Cameron E Perry; Bret M Evers; Thomas G Gillette; Michael Kyba; Maria Trojanowska; Joseph A Hill
Journal:  Circ Res       Date:  2021-09-21       Impact factor: 17.367

Review 4.  Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.

Authors:  Rita Wen Kaspar; Hugh D Allen; Federica Montanaro
Journal:  J Am Acad Nurse Pract       Date:  2009-05

5.  Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy.

Authors:  Diem-Hang Nguyen-Tran; Nitai C Hait; Henrik Sperber; Junlin Qi; Karin Fischer; Nick Ieronimakis; Mario Pantoja; Aislinn Hays; Jeremy Allegood; Morayma Reyes; Sarah Spiegel; Hannele Ruohola-Baker
Journal:  Dis Model Mech       Date:  2013-09-25       Impact factor: 5.758

Review 6.  Myocardial and Arrhythmic Spectrum of Neuromuscular Disorders in Children.

Authors:  Anwar Baban; Valentina Lodato; Giovanni Parlapiano; Corrado di Mambro; Rachele Adorisio; Enrico Silvio Bertini; Carlo Dionisi-Vici; Fabrizio Drago; Diego Martinelli
Journal:  Biomolecules       Date:  2021-10-25

Review 7.  The heart and cardiac pacing in Steinert disease.

Authors:  Gerardo Nigro; Andrea Antonio Papa; Luisa Politano
Journal:  Acta Myol       Date:  2012-10

8.  Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment.

Authors:  Corinne Betts; Amer F Saleh; Andrey A Arzumanov; Suzan M Hammond; Caroline Godfrey; Thibault Coursindel; Michael J Gait; Matthew Ja Wood
Journal:  Mol Ther Nucleic Acids       Date:  2012-08-14       Impact factor: 10.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.